SCYX FY 2023 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$140M+2652.7% YoY

Gross Profit

$125M88.9% margin

Operating Income

$73M51.9% margin

Net Income

$67M47.8% margin

EPS (Diluted)

$1.39

Cash Flow

Operating Cash Flow

$60M

Free Cash Flow

$60M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$128M

Total Liabilities

$55M

Stockholders' Equity

$73M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$140M	$5M	+2652.7%
Gross Profit	$125M	$4M	+2690.0%
Operating Income	$73M	-$86M	+184.7%
Net Income	$67M	-$63M	+206.7%